Pharmacovigilance in Clinical Trials
- 1° EDITION: 24 November 2026
- 2° EDITION: 13 April 2027
- Online
Italian
- 1° EDITION: 24 November 2026
- 2° EDITION: 13 April 2027
- Online
-
Italiano
Training overview
One of the main priorities of a clinical trial is the safety of the subjects enrolled in it. For this reason, pharmacovigilance in clinical trials is one of the most important aspects to consider for proper risk assessment of the experimental drug. Therefore, it should always be evolving and adapted to regional and local regulations. The introduction of Regulation (EU) No. 536/2014 of the European Parliament is a new challenge to be faced but at the same time an opportunity for an area, such as Europe, hitherto fragmented by various local regulations. For the purpose of assessing the benefit-risk ratio, the Development Safety Update Report (DSUR) is a mandatory annual report to be submitted to the Competent Authority and aimed at informing about the progress of the clinical trial and the safety risk analysis of the investigational drug under study, comparing also with worldwide experience, so as to ensure proper protection for enrolled subjects.
Key points of the training
- Reference legislation for pharmacovigilance in clinical trials
- Which figures are involved and their responsibilities
- Proper management of pharmacovigilance in clinical trials
- How to establish a proper relationship between Sponsors and CROs and what information is necessary for pharmacovigilance for drafting the documents
- What is the format of the DSUR and what information needs to be presented and analysed
09:30 – 12:30 MORNING SESSION
14:00 – 17:00 AFTERNOON SESSION
- Normative requirements
- Types of clinical trials
- Figures involved and responsibilities
- Management of reports from clinical trials
- Safety Management Plan
- Development Safety Update Report
Personnel involved in the areas of Pharmacovigilance, Clinical, Regulatory Affairs. The course provides the theoretical basis necessary for the correct management of pharmacovigilance in clinical trials and provides indications regarding the management and planning of the DSUR to be submitted.
The course will be carried out through live lectures. Practical examples will be showcased, providing delegates with real life examples to be applied in their daily job life.
For online trainings the access link will be sent 2-3 days before the start of the training.
Attendance to the event will be allowed upon receipt of payment.
5% discount for registrations within 1 month before the start of the training, 10% discount for registrations within 2 months before the start of the training. VAT not included. Please inquire for discounts for multiple registrations. Discounts are not cumulative.
Cancellation terms
In order to cancel enrolment to an event, please email info@pharmaeducationcenter.it within 2 weeks before the starting date of the event. Once this term will be expired, the entire fee will be charged.
Participant replacement
It is possible to replace a participant attendance without additional cost, simply by contacting info@pharmaeducationcenter.it. It is asked to notify the participant replacement request within 5 days before the starting date of the course/event, specifying the full name and surname of the enrolled participant as well as the full name and surname of the substitute.
Training cancellation
If the minimum number of participants is not reached, Pharma Education Center reserves the right to cancel or schedule the event for another date. Formal communication will be given within 5 days before the event date. In this case Pharma Education Center will refund the registration fee in full and without additional charges. Alternatively, the participant can request a spendable coupon for participating in another PEC event scheduled in the current year.
Speakers

Monica Ruggiero
Senior Drug Safety Officer presso Product Life Italia
Laureata nel 2001 in Scienze Biologiche presso l’Università Federico II di Napoli, in seguito consegue il Master di II livello in “Sperimentazione Clinica del Farmaco” presso l’Università di Tor Vergata Roma. Ha iniziato la sua attività lavorativa nella ricerca clinica dell’azienda farmaceutica Abbott Srl, come CRA e poi come PHV Analyst, successivamente ha lavorato come Senior Pharmacovigilance Analyst nel dipartimento di farmacovigilanza di Mylan. Dal 2017 è Team Leader Senior Drug Safety Officer presso Pharma D&S, adesso Product Life Italia, e si occupa di farmacovigilanza pre-marketing e post-marketing; inoltre si occupa di attività formative all’interno di Pharma Education Center.
Interested in Clinical Research training?
Enroll in 3 courses and you’ll get a 15% discount*, while choosing 5 courses will grant you a 20% discount*!
Choose among these titles:
- L’Investigator nella Ricerca Clinica
- CTIS: Guida all’Utilizzo del Nuovo Portale Europeo
- La Documentazione della Sperimentazione Clinica
- Gli Studi Osservazionali
(*) discounts apply to the full prices of the courses and cannot be combined with other promotions. The promotion is limited to enrolling the same person in 3 or 5 courses selected from those offered.
Register now
880€
Training materials available for attendees
Certificate of attendance
Senior trainers with hands-on experience
You may also be interested in...
- 6 October 2026
- 15 June 2027
- Online
- 13 Ottobre 2026
- 10 Marzo 2027
- Online
- 22 October 2026
- 18 March 2027
- Online
- 23 October 2026
- 8 March 2027
- Online
- 26 Ottobre 2026
- 25 Marzo 2027
- Online
- 26 Ottobre 2026
- 6 Maggio 2027
- Online
- 3 November 2026
- 24 April 2027
- Online
- 4-5 November 2026
- 9-10 March 2027
- Online
- 10-11 Novembre 2026
- 20-21 Aprile 2027
- Online
- 15-16 Dicembre 2026
- 14-15 Giugno 2027
- Online
- 16-17 December 2026
- 28-29 June 2027
- Online
During the training course "Medical Device Regulatory Affairs", key issues for those who want to operate or work in this [...]
- 26-27 Maggio 2027
- Online